Payne JF, Ray R, Watson DG, Delille C, Rimler E, Cleveland J, et al. "Vitamin D insufficiency in diabetic retinopathy". Endocrine Practice 2011; Sep 22: 1-18, PMID 21940279, PMC 4706181.
Wang K, D'Argenio DZ, Acosta EP, Sheth AN, Delille C, Lennox JL, Kerstner-Wood C, Ofotokun I. "Integrated population pharmacokinetic/viral dynamic modeling of lopinavir/ritonavir in HIV-1 treatment naive patients". Clinical Pharmacokinetics 2014 Apr; 53: 361-371. PMID 24311282, PMC 3962720.
Delille CA, Pruett ST, Marconi VC, Lennox JL, Armstrong WS, Ofotokun I, et al. "Effect of protein binding on unbound atazanavir and darunavir cerebrospinal fluid concentrations". Journal of Clinical Pharmacology 2014, Sep; 54 (9): 1063-1071. PMID 24691856, PMC 4396178.
D'Souza G, Burk RD, Palefsky JM, Massad LS, Strickler HD, WIHS HPV Working Group. "Cervical human papillomavirus testing to triage borderline abnormal pap tests in HIV-coinfected women". AIDS 2014, July 17; 28: 1696-1698. PMID 25232904, PMC 4196721.
Titanji K, Vunnava A, Sheth AN, Delille C, Lennox JL, Sanford SE, Foster A, Easley KA, Weitzmann MN, Ofotokun I. "Dysregulated B cell expression of RANKL and OPG reflects bone loss in HIV infection". PLoS Pathogen 2014, Nov 13; 10 (10): e1004497. PMID 25393853, PMC 4231117.
Lahiri CD, Tao S, Sheth AN, Acosta EP, Marconi VC, Armstrong WS, Schinazi RF, Vunnava A, Sanford S, Ofotokun I. "Impact of protease inhibitors on intracellular concentration of tenofovir-diphosphate among HIV-1 infected patients". AIDS 2015, June 1; 29 (9): 1113-1115. PMID 25870991, PMC 4490037.
Lahiri CD, Dugan KB, Xie X, Reimers L, Burk RD, Anastos K, et al. "Oral lopinavir use and human papillomavirus infection in HIV-positive women". JAIDS 2015, October 1; 70 (2): e63-66. PMID 26181819, PMC 4573346.
Ofotokun I, Titanji K, Vunnava A, Roser-Page S, Vikulina T, Villinger F, Rogers K, Sheth AN, Lahiri CD, Lennox JL, Weitzmann NM. "Antiretroviral therapy induces a rapid increase in bone resorption that is positively associated with the magnitude of immune reconstitution in HIV infection". AIDS 2016, January 28; 30 (3): 405-414. PMID 26760232, PMC 4712729.
ahiri CD, Reed-Walker K, Sheth AN, Acosta EP, Vunnava A, Ofotokun I. "Cerebrospinal fluid concentrations of tenofovir and emtricitabine in the setting of HIV-1 protease inhibitor-based regimens". Journal of Clinical Pharmacology April 2016; 56 (4): 492-496: PMID 26247878, PMC 4744587.
Ofotokun I, Titanji K, Lahiri CD, Vunnava A, Foster A, Sanford SE, Sheth AN, Lennox JL, Knezevic A, Ward L, Easley KA, Powers P, Weitzmann MN. "A single dose zoledronic acid infusion prevents antiretroviral therapy-induced bone loss in treatment-naïve HIV-infected patients: a Phase IIb Trial". Clinical Infectious Diseases 2016, Sept 1, 63 (5): 663-671. PMID 27193748, PMC 4981757
Vergara C, Thio C, Latanich R, Cox A, Kirk G, Mehta S, Busch M, Murphy E, Villacres M, Peters M, French A, Golub E, Eron J, Lahiri C, Shrestha S, Gustafson D, Young M, Anastos K, Aouizerat B, Kim A, Lauer G, Thomas D, Duggal P. "Genetic basis for variation in plasma IL-18 levels in persons with chronic hepatitis C virus and human immunodeficiency virus-1 infections". Genes and Immunity 2017 Mar; 18 (2): 82-87. PMID 28300059, PMC 5408324.
Frank M, Lahiri CD, Nguyen ML, Mehta CC, Mosunjac M, Flowers L. "Factors associated with anal high-grade squamous intraepithelial lesion in HIV positive men in a southern U.S. city". AIDS Res Hum Retroviruses 2018, July; 34 (7): 598-602. PMID 29607650, PMC 6025845.
Lahiri CD, Brown NL, Ryan KJ, Acosta EP, Sheth AN, Mehta CC, Ingersoll J, Ofotokun I. "HIV RNA persists in rectal tissue despite rapid plasma virologic suppression with dolutegravir-based therapy". AIDS 2018, Sept 24; 32 (15): 2151-2159. PMID 30005011, PMC 6200454.
Lahiri CD, Nguyen ML, Mehta CC, Mosunjac M, Tadros T, Unger ER, Rajeevan MS, Richards J, Ofotokun I, Flowers L. "Pilot study of markers for high-grade anal dysplasia in a southern cohort from the Women's Interagency HIV Study (WIHS)". Clinical Infectious Diseases, 2020, March 3; 70(6): 1121-1128, PMID 31058984, PMC 7319055. *Commentary by SE Bennett, CID 2020 Mar 3; 70(6): 1129-1130, PMID 31058969.
Kerchberger AM, Sheth AN, Angert CD, Mehta CC, Summers NA, Ofotokun I, Gustafson D, Weiser SD, Sharma S, Adimora AA, French AL, Augenbraun M, Cocohoba J, Kassaye S, Bolivar H, Govindarajulu U, Konkle-Parker D, Golub ET, Lahiri CD. "Weight gain associated with integrase strand transfer inhibitor use in women". Clinical Infectious Diseases, 2020, Jul 27; 71 (3): 593-600. PMID 31504324, PMC 73843
Collins LF, Moran CA, Oliver NT, Moanna A, Lahiri CD, Colasanti JA, Kelley CF, Nguyen ML, Marconi VC, Armstrong WS, Ofotokun I, Sheth AN. "Clinical characteristics, comorbidities, and outcomes among persons with HIV hospitalized with coronavirus disease 2019 in Atlanta, Georgia", AIDS, 2020, Oct 1; 34(12): 1789-1794, PMID 32675581, PMC 7484356
Ofotokun I, Collins LF, Titanji T, Foster A, Moran CA, Sheth AN, Lahiri CD, Lennox JL, Ward L, Easley KA, Weitzmann MN. "Antiretroviral therapy-induced bone loss is durably suppressed by a single dose of zoledronic acid in treatment-naive persons living with HIV infection: A phase IIb trial." Clinical Infectious Diseases, 2020, Oct 23; 71(7): 1655-1663, PMID 31621838.
D'Souza G, Springer G, Gustafson D, Kassaye S, Alcaide ML, Ramirez C, Sharma A, Palella FJ, Tien PC, Detels R, Kempf MC, Lahiri CD, Rinaldo CR, French AL, Margolick JB, Adimora AA. "COVID-19 symptoms and SARS-CoV-2 infection among people living with HIV in the US: The MACS/WIHS Combined Cohort Study." HIV Research and Clinical Practice, 2020 Oct;21(5):130-139. PMID 33211636; PMC 7682380
Summers NA, Lahiri CD, Angert CD, Aldredge A, Mehta CC, Ofotokun I, Kerchberger AM, Gustafson D, Weiser S, Kassaye S, Konkle-Parker D, Sharma A, Adimora AA, Bolivar H, Sheth AN. "Metabolic changes associated with the use of integrase strand transfer inhibitors among virally-suppressed women", Journal of Acquired Immunodeficiency Syndrome, 2020 Nov 1; 85 (3): 355-362, PMID 33060420, PMC 7577246.
Kamkwalala AR, Wang K, O'Halloran J, Williams DW, Dastgheyb R, Fitzgerald KC, Spence AB, Maki PM, Gustafson DR, Milam J, Sharma A, Weber KM, Adimora AA, Haughey NJ, Ofotokun I, Sheth AN, Lahiri CD, Fischl MA, Konkle-Parker D, Xu Y, Rubin LH. "Starting or switching to an integrase inhibitor-based regimen affects PTSD symptoms in women with HIV", AIDS Behav. 2021 Jan;25(1):225-236. PMID 32638219; PMC: PMC7948485.
Lahiri CD, Xu Y, Wang K, Alvarez JAA, Sheth AN, O'Halloran J, Spence AB, Tien P, Gustafson DR, Milam J, Fischl MA, Konkle-Parker D, Adimora AA, Sharma A, Weber KM, Ofotokun I, Rubin LH. "Weight and body mass index change after switching to integrase inhibitors or tenofovir alafenamide among women living with HIV". AIDS Res Hum Retroviruses. 2021 Jun; 37(6): 461-467, PMID: 33231474. *Commentary by F Macaluso and DR Gustafson in J AIDS HIV Treat, 2021; 3(2):21-23, PMID 34291233.
Collins LF, Colasanti JA, Nguyen ML, Moran CA, Lahiri CD, Marconi VC, Armstrong WS, Shah NS. "The COVID-19 pandemic as a catalyst for differentiated care models to end the HIV epidemic in the U.S"applying lessons from high-burden settings". AIDS, 2021 Feb 2;35(2):337-341, PMID 33165032; PMC 7775326
O'Halloran JA, Wang K, Spencer AB, Williams DW, Dastgheyb R, Fitzgerald KC, Kamkwalala AR, Maki PM, Sharma A, Gustafson DR, Milam J, Weber KM, Adimora AA, Ofotokun I, Fischl MA, Konkle-Parker D, Lahiri CD, Sheth AN, Xu Y, Rubin LH. "Integrase strand transfer inhibitor start or switch impacts learning in women with HIV", J Acquir Immune Defic Syndr. 2021 Apr 15;86(5):593-599. PMID 33394812
Herbertson EC, Lahiri CD, Nwogu JN, Soremekun RO, Olugbake OA, Ezechi OC, Gandhi M, Akanmu AS. "Willingness to donate hair sample and other biological samples for research among people living with HIV in an outpatient clinic in Lagos, Nigeria." AIDS Research and Human Retroviruses, 2021 Sep; 37(9): 676-682, PMID 33687274.
D'Souza G, Tong W, Gustafson D, Alcaide ML, Lahiri CD, Sharma A, French AL, Palella FJ, Kempf M-C, Mimiaga M, Ramirez C, Kassaye S, Rinaldo CR, Brown T, Tien PC, Adimora AA. "SARS-CoV-2 infection among people living with HIV compared to people without HIV: Survey results from the MACS-WIHS Combined Cohort Study." JAIDS, 2022 Jan 1; 89(1): 1-8, PMID 34878431.
Galaviz KI, Shah NS, Gutierrez M, Collins LF, Lahiri CD, Moran CA, Szabo B, Sumitani J, Rhodes J, Marconi VC, Nguyen ML, Cantos VD, Armstrong WS, Colasanti JS. "Patient experiences with telemedicine for HIV care during the first COVID-19 wave". AIDS Research and Human Retroviruses 2021 Nov 29, online ahead of print, PMID 34693726.
Anderson AM, Bhondoekhan F, Curanovic D, Connelly MA, Otvos JD, Post W, Michos ED, Lahiri CD, Wolinsky S, Levine A, Seaberg E, Rubin LH, Vance DE, Becker JT. "GlycA is associated with neuropsychological impairment in men with HIV." AIDS 2022, Jan 1; 36 (1): 156-9. PMID: 34873097.
Spence AB, Liu C, Rubin LH, Aouizerat B, Vance D, Bolivar H, Lahiri CD, Adimora AA, Weber K, Gustafson D, Sosanya O, Turner RS, Kassaye SG. "Class-based antiretroviral exposure and cognition among women living with HIV (WLWH)." AIDS Research and Human Retroviruses. 2022 Feb 2, online ahead of print. PMID 35109713.
Janorkar D, Long D, Weber KM, Sharma A, Lin G-H, D'Souza G, Edmonds A, Kassaye S, Lahiri CD, Konkle-Parker D. "Association between BMI and Periodontitis in Women Living with or At Risk for HIV". Special Care in Dentistry, 2022, March 13, online ahead of print. PMID 35279851. https://www.ncbi.nlm.nih.gov/sites/myncbi/185s0WAikJL58/collections/47810926/public/
